Skip to main content
Medical Science Monitor: International Medical Journal of Experimental and Clinical Research logoLink to Medical Science Monitor: International Medical Journal of Experimental and Clinical Research
. 2022 Mar 4;28:e936562-1. doi: 10.12659/MSM.936562

Retracted: Targeting Transforming Growth Factor-Beta1 (TGF-β1) Inhibits Tumorigenesis of Anaplastic Thyroid Carcinoma Cells Through ERK1/2-NFκB-PUMA Signaling

Qiang Yin 1, Shan Liu 1, Anbing Dong 2, Xiufang Mi 3, Fengyun Hao 4, Kejun Zhang 2,
PMCID: PMC8902839  PMID: 35241640

Retraction Notice:

The in vitro experiments of TGF-β1 and the results of RT-PCR could not be repeated. In order not to affect others, the authors have asked for a retraction.

Reference

  1. Yin Qiang, Liu Shan, Dong Anbing, Mi Xiufang, Hao Fengyun, Zhang Kejun. Targeting Transforming Growth Factor-Beta1 (TGF-β1) Inhibits Tumorigenesis of Anaplastic Thyroid Carcinoma Cells Through ERK1/2-NFκB-PUMA Signaling. Med Sci Monit. 2016;22:2267–2277. doi: 10.12659/MSM.898702. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]

Articles from Medical Science Monitor : International Medical Journal of Experimental and Clinical Research are provided here courtesy of International Scientific Information, Inc.

RESOURCES